The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
Serum fibroblast growth factor 23 (FGF-23) levels are markedly elevated in haemodialysis patients and have been linked to mortality outcomes. Small studies in health and chronic kidney disease, have demonstrat...
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Matthew J. Damasiewicz, Zhong X. Lu, Peter G. Kerr and Kevan R. Polkinghorne Tags: Research article Source Type: research